Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Conditions
Bladder Cancer · Urothelial Carcinoma (UC) · Hematuria · Upper Tract Urothelial Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Urology San Diego, Oceanside, California, United States
Genesis Research, LLC, San Diego, California, United States
Urology Associates of Silicon Valley, San Jose, California, United States
UroPartners, LLC, Chicago, Illinois, United States
UroPartners, LLC, Grayslake, Illinois, United States
UroPartners, LLC, Mount Prospect, Illinois, United States
UroPartners, LLC, Niles, Illinois, United States
UroPartners, LLC, Wheaton, Illinois, United States
Chesapeake Urology Research Associates, Hanover, Maryland, United States
Comprehensive Urology, Royal Oak, Michigan, United States
Sheldon J. Freedman MD LTD, Las Vegas, Nevada, United States
Manhattan Medical Research Practice, New York, New York, United States
The Urology Group, Cincinnati, Ohio, United States
Urology Associates, P.C., Nashville, Tennessee, United States
Urology Austin - Round Rock, Austin, Texas, United States
Midtown Urology Associates, Austin, Texas, United States
Urology Austin - Medical Park Tower, Austin, Texas, United States
UT Southwestern Medical Center, Dallas, Texas, United States
Urology San Antonio, San Antonio, Texas, United States
UT Health San Antonio, San Antonio, Texas, United States
Urology of Virginia, Virginia Beach, Virginia, United States
Ashford Med Center, San Juan, Puerto Rico
PanOncology, San Juan, Puerto Rico